Global Markets for Emerging Insulin Drug and Delivery Technologies

Published - Aug 2013| Analyst - Shalini Shahani Dewan| Code - HLC149A
Market Research Report Single User License: $3990

Report Highlights

The global market for insulin drug and delivery devices totaled $24 billion in 2012. The overall insulin drug and device market is projected to be worth $25.7 billion by 2013 and $40.2 billion by 2018, a five-year compound annual growth rate (CAGR) for of 9.3% from 2013 to 2018.

This report provides:

  • An overview of global insulin drugs and delivery in pharmaceutical and biotechnology markets with classification and usage in diabetes types.
  • Analyses of global market trends, with data from 2011 and 2012, estimates for 2013 and 2018 and projections of compound annual growth rates (CAGRs) through 2018.
  • Discussion of the market segmented by insulin syringes and vials, and insulin pens and insulin pumps.
  • Evaluation of emerging technologies in the insulin drug and delivery field that have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods.
  • Patent identifications for insulin as a drug, along with its delivery methods.


The scope of this study encompasses insulin drugs and delivery in pharmaceutical and biotechnology markets with its classification and its usage in diabetes types. BCC analyzes each market and its applications, as well as its regulatory environment, technology and market share. The markets, such as type 1 diabetes, type 2 diabetes and gestational diabetes, are analyzed for the years 2011 and 2012. The markets are projected through the end of 2013 and for a five-year period until 2018.

The market is also segmented by insulin syringes and vials, insulin pens and insulin pumps. Technological issues include the latest trends and developments. The study also includes the patent identifications for insulin as a drug, along with its deliveries.

The emerging markets for insulin drug and delivery include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.


A team of professionals in the biotechnology industry carried out this study. The project manager is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has more than 14 years of industry experience. She has worked studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid, along others. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has also worked with top companies in India and in the U.S. Her reports BCC Research reports include Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.

The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in the life sciences. She has a number of research publications to her credit.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at(+1) 781-489-7301 or contact us at
Title/Chapter Name Pages Price
Full Report: Global Markets for Emerging Insulin Drug and Delivery Technologies 169 $3990
Chapter- 1: INTRODUCTION 3
Chapter- 2: SUMMARY 3 $250
Chapter- 3: OVERVIEW 18 $637
Chapter- 4: REGULATORY ASPECTS 11 $390
Chapter- 5: NEW DEVELOPMENTS 14 $496
Chapter- 6: GLOBAL MARKETS 23 $815
Chapter- 10: PATENT ANALYSIS 7 $248
Chapter- 11: CURRENT SITUATION 7 $248
Chapter- 12: COMPANY PROFILES 19 $673
List of Tables
List of Figures
Download Table of Contents
Share This Report